sunitinib (multitarget rtk inhibitor) Search Results


sunitinib (multitarget rtk inhibitor)  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals sunitinib (multitarget rtk inhibitor)
Preclinical antivascular and antiangiogenic studies that used vessel-calibre MRI
Sunitinib (Multitarget Rtk Inhibitor), supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sunitinib (multitarget rtk inhibitor)/product/MultiTarget Pharmaceuticals
Average 90 stars, based on 1 article reviews
sunitinib (multitarget rtk inhibitor) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Preclinical antivascular and antiangiogenic studies that used vessel-calibre MRI

Journal: Nature reviews. Clinical oncology

Article Title: Vessel calibre—a potential MRI biomarker of tumour response in clinical trials

doi: 10.1038/nrclinonc.2014.126

Figure Lengend Snippet: Preclinical antivascular and antiangiogenic studies that used vessel-calibre MRI

Article Snippet: Sunitinib (multitarget RTK inhibitor); 60 mg/kg per day , MDA-MB-435 melanoma in mice (10) 118 , ↓ ( P <0.05) , ↓ ( P <0.05) , Day 7.

Techniques: Inhibition, Disruption